“High dosage of Prostate-Specific Antigen (PSA) in a patient after radical prostatectomy and without clinical evidence to support tumor recurrence: case report” (2021) Research, Society and Development, 10(13), p. e93101321104. doi:10.33448/rsd-v10i13.21104.